Ghent biotech company develops new strategy for the treatment of cancer and fibrosis
This item is under embargo and is only visible to journalists
Please login here
Regions: Europe, Belgium
Keywords: Health, Medical, Business, Knowledge transfer, Medical & pharmaceutical, Universities & research, Science, Life Sciences
The item has been withdrawn. If you are a journalists please contact the person that posted the item with any questions.